Ovid Therapeutics Inc.
OVID
Revenue
169.00k
▲21.00k▲14.19%
3 Months ChangeAssets
118.09M
▼-13.52M▼-10.27%
3 Months ChangeLiabilities
29.19M
▼-24.14M▼-45.27%
3 Months ChangeFree Cash Flow
-16.71M
▼-4.58M▼-37.76%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-11
Form 8-K
ID: 0001193125-24-217302
2024-08-13
Form 10-Q
ID: 0001628280-24-036860
2024-08-13
Form 8-K
ID: 0001628280-24-036859
2024-08-02
Form 8-K
ID: 0001628280-24-034481
2024-07-01
Form 8-K
ID: 0001628280-24-030546
2024-06-28
Form 8-K
ID: 0001193125-24-172225
2024-06-17
Form 8-K
ID: 0000950170-24-073998
2024-06-07
Form 8-K
ID: 0000950170-24-070673
2024-05-14
Form 10-Q
ID: 0001628280-24-023067
2024-05-14
Form 8-K
ID: 0001628280-24-023064